Research ArticleSpecial Communication
The Potential Emergence of Disease-Modifying Treatments for Alzheimer Disease: The Role of Primary Care in Managing the Patient Journey
Jenny Lam, Jakub Hlávka and Soeren Mattke
The Journal of the American Board of Family
Medicine November 2019, 32 (6) 931-940; DOI: https://doi.org/10.3122/jabfm.2019.06.180328
Jenny Lam
From the Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles, CA (JM); Price School of Public Policy, University of Southern California, Los Angeles, CA (JH); Center for Economic and Social Research, University of Southern California, Los Angeles, CA (SM).
MD, MASJakub Hlávka
From the Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles, CA (JM); Price School of Public Policy, University of Southern California, Los Angeles, CA (JH); Center for Economic and Social Research, University of Southern California, Los Angeles, CA (SM).
PhDSoeren Mattke
From the Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles, CA (JM); Price School of Public Policy, University of Southern California, Los Angeles, CA (JH); Center for Economic and Social Research, University of Southern California, Los Angeles, CA (SM).
MD, DScReferences
- 1.↵
- Selkoe DJ
- 2.↵EISAI and Biogen Announce Detailed Results of Phase II Clinical Study of BAN2401 in Early Alzheimer's Disease At Alzheimer's Association International Conference (AAIC) 2018 [Press Release]. Eisai Co., Ltd. and Biogen Inc., July 26 2018.
- 3.↵
- Liu JL,
- Hlávka JP,
- Hillestad R,
- Mattke S
- 4.↵
- 5.↵
- Cognat E,
- Mouton Liger F,
- Troussière AC,
- et al
- 6.↵
- Rajan KB,
- Weuve J,
- Barnes LL,
- Wilson RS,
- Evans DA
- 7.↵
- 8.↵
- Albert MS,
- DeKosky ST,
- Dickson D,
- et al
- 9.↵
- McKhann GM,
- Knopman DS,
- Chertkow H,
- et al
- 10.↵
- Sperling RA,
- Aisen PS,
- Beckett LA,
- et al
- 11.↵
- Jack CR Jr.,
- Knopman DS,
- Jagust WJ,
- et al
- 12.↵
- 13.↵
- Knopman DS,
- Petersen RC
- 14.↵Safety and Efficacy study of gantenerumab in participants with early Alzheimer's disease (AD). Available from: https://ClinicalTrials.gov/show/NCT03443973. Accessed March 17, 2019.
- 15.↵Efficacy and Safety study of gantenerumab in participants with early Alzheimer's disease (AD). Available from: https://ClinicalTrials.gov/show/NCT03444870. Accessed March 17, 2019.
- 16.↵A study to confirm safety and efficacy of BAN2401 in participants with early Alzheimer's disease. Available from: https://ClinicalTrials.gov/show/NCT03887455. Accessed June 22, 2019.
- 17.↵A study of LY3002813 in participants with early symptomatic Alzheimer's disease (TRAILBLAZER-ALZ). Available from: https://ClinicalTrials.gov/show/NCT03367403. Accessed March 17, 2019.
- 18.↵A study to evaluate the efficacy and safety of ABBV-8E12 in subjects with early Alzheimer's disease. Available from: https://ClinicalTrials.gov/show/NCT02880956. Accessed March 17, 2019.
- 19.↵A study to evaluate the efficacy and safety of RO7105705 in patients with prodromal to mild Alzheimer's disease. Available from: https://ClinicalTrials.gov/show/NCT03289143. Accessed March 17, 2019.
- 20.↵A 24-month study to evaluate the efficacy and safety of E2609 in subjects with early Alzheimer's disease_ (MissionAD2). Available from: https://ClinicalTrials.gov/show/NCT03036280. Accessed March 17, 2019.
- 21.↵A study of CNP520 versus placebo in participants at risk for the onset of clinical symptoms of Alzheimer's disease. Available from: https://ClinicalTrials.gov/show/NCT03131453. Accessed March 17, 2019.
- 22.↵A study of CAD106 and CNP520 versus placebo in participants at risk for the onset of clinical symptoms of Alzheimer's disease. Available from: https://ClinicalTrials.gov/show/NCT02565511. Accessed March 17, 2019.
- 23.↵24 months safety and efficacy study of AADvac1 in patients with mild Alzheimer's disease. Available from: https://ClinicalTrials.gov/show/NCT02579252. Accessed March 17, 2019.
- 24.↵
- 25.↵
- Khan A,
- Corbett A,
- Ballard C
- 26.↵
- Petersen RC,
- Lopez O,
- Armstrong MJ,
- et al
- 27.↵
- Cordell CB,
- Borson S,
- Boustani M,
- et al
- 28.↵Gerontological Society of America (GSA) workgroup on cognitive impairment detection and earlier diagnosis. KAER—A 4-step process to detecting cognitive impairment and earlier diagnosis of dementia. Available from: https://www.geron.org/images/gsa/kaer/gsa-kaer-toolkit.pdf. Published 2017. Accessed March 3, 2019.
- 29.↵
- Lin JS,
- O'Connor E,
- Rossom RC,
- et al
- 30.↵
- Tsoi KK,
- Chan JY,
- Hirai HW,
- Wong SY,
- Kwok TC
- 31.↵
- Lonie JA,
- Tierney KM,
- Ebmeier KP
- 32.↵
- Ozer S,
- Young J,
- Champ C,
- Burke M
- 33.↵
- Weissberger GH,
- Strong JV,
- Stefanidis KB,
- Summers MJ,
- Bondi MW,
- Stricker NH
- 34.↵
- Williamson JC,
- Larner AJ
- 35.↵
- Folstein MF,
- Folstein SE,
- McHugh PR
- 36.↵
- 37.↵
- 38.↵
- Nieuwenhuis-Mark RE
- 39.↵
- 40.↵
- Nasreddine ZS,
- Phillips NA,
- Bédirian V,
- et al
- 41.↵
- 42.↵
- 43.↵
- Mellor D,
- Lewis M,
- McCabe M,
- et al
- 44.↵
- Luis CA,
- Keegan AP,
- Mullan M
- 45.↵
- Roalf DR,
- Moberg PJ,
- Xie SX,
- Wolk DA,
- Moelter ST,
- Arnold SE
- 46.↵
- Ciesielska N,
- Sokołowski R,
- Mazur E,
- Podhorecka M,
- Polak-Szabela A,
- Kedziora-Kornatowska K
- 47.↵
- 48.↵
- 49.↵
- 50.↵
- 51.↵
- Larner AJ
- 52.↵
- Berg JL,
- Durant J,
- Léger GC,
- Cummings JL,
- Nasreddine Z,
- Miller JB
- 53.↵
- Wild K,
- Howieson D,
- Webbe F,
- Seelye A,
- Kaye J
- 54.↵
- Darby DG,
- Fredrickson J,
- Pietrzak RH,
- Maruff P,
- Woodward M,
- Brodtmann A
- 55.↵
- Buckley RF,
- Sparks KP,
- Papp KV,
- et al
- 56.↵
- 57.↵
- Yang H,
- Lyutvinskiy Y,
- Herukka SK,
- Soininen H,
- Rutishauser D,
- Zubarev RA
- 58.↵
- Hye A,
- Riddoch-Contreras J,
- Baird AL,
- et al
- 59.↵
- DeMarshall CA,
- Nagele EP,
- Sarkar A,
- et al
- 60.↵
- Yamamoto-Imoto H,
- Zamolodchikov D,
- Chen ZL,
- et al
- 61.↵
- 62.↵
- Zarrouk A,
- Debbabi M,
- Bezine M,
- et al
- 63.↵
- 64.↵
- Donohue MC,
- Moghadam SH,
- Roe AD,
- et al
- 65.↵
- 66.↵
- Ritchie C,
- Smailagic N,
- Noel-Storr AH,
- et al
- 67.↵
- 68.↵
- Fandos N,
- Perez-Grijalba V,
- Pesini P,
- et al
- 69.↵
- 70.↵
- Blennow K
- 71.↵
- Mielke MM,
- Hagen CE,
- Xu J,
- et al
- 72.↵
- Chen Z,
- Mengel D,
- Keshavan A,
- et al
- 73.↵
- Mattsson N,
- Andreasson U,
- Zetterberg H,
- Blennow K
- 74.↵
- Abbasi J
- 75.↵
- Koronyo-Hamaoui M,
- Koronyo Y,
- Ljubimov AV,
- et al
- 76.↵
- Garrard P,
- Nemes V,
- Nikolic D,
- Barney A
- 77.↵
- Khodabakhsh A,
- Demiroglu C
- 78.↵
- Beltrán J,
- Garcia-Vazquez MS,
- Benois-Pineau J,
- Gutierrez-Robledo LM,
- Dartigues JF
- 79.↵
- Silva MME,
- Mercer PBS,
- Witt MCZ,
- Pessoa RR
- 80.↵
- Jung HJ,
- Shin IS,
- Lee JE
- 81.↵
- 82.↵
- Horvath A,
- Szucs A,
- Csukly G,
- Sakovics A,
- Stefanics G,
- Kamondi A
- 83.↵
- Nobukawa S,
- Yamanishi T,
- Nishimura H,
- Wada Y,
- Kikuchi M,
- Takahashi T
- 84.↵
- Kanda PAM,
- Oliveira EF,
- Fraga FJ
- 85.↵U.S. Census Bureau, Population Division. Projected 5-Year Age Groups and Sex Composition: Main Projections Series for the United States, 2017–2060. Available from: https://www.census.gov/data/tables/2017/demo/popproj/2017-summary-tables.html. Accessed January 31, 2019.
- 86.
- Gauthier S,
- Reisberg B,
- Zaudig M,
- et al
- 87.↵Will Europe be ready for the treatment of Alzheimer's disease? Lancet Neurol 2018;17:1025.
In this issue
The Journal of the American Board of Family
Medicine
Vol. 32, Issue 6
November-December 2019
The Potential Emergence of Disease-Modifying Treatments for Alzheimer Disease: The Role of Primary Care in Managing the Patient Journey
Jenny Lam, Jakub Hlávka, Soeren Mattke
The Journal of the American Board of Family
Medicine Nov 2019, 32 (6) 931-940; DOI: 10.3122/jabfm.2019.06.180328
Related Articles
- No related articles found.